Frontier Acquisition Corp.
We intend to capitalize on the ability of our management team to identify promising opportunities at the intersection of the healthcare and technology industries, specifically within the biotechnology sector. (Incorporated in the Cayman Islands)
Our sponsor is an affiliate of Apeiron Investment Group, a private limited company incorporated in Malta, and Falcon Edge Capital.
Apeiron is the family office and merchant banking business of Christian Angermayer. Apeiron focuses across a number of industries, including life sciences, financial services, deep technology, media and entertainment and real estate. Apeiron has a strong track record of success within the healthcare and technology industries. Within the biotechnology sector, Apeiron’s investments include COMPASS Pathways, AbCellera, atai Life Sciences, Cambrian Biopharma and Rejuveron Life Sciences.
Founded in 2012, Falcon Edge Capital is a diversified global alternative asset manager led by Rick Gerson, Ryan Khoury and Navroz Udwadia. Falcon Edge Capital manages about $4.3 billion of client assets across a range of private investment funds and separately managed accounts following long/short equity, venture capital and special situations investment mandates. Some of Falcon Edge Capital’s prior investments in the private markets include: SpaceX, Ant Financial, Ola, Alibaba, Uber, Lyft and AbCellera.
|Address||660 Madison Avenue, 19th Floor, New York, New York 10065|
|View Prospectus:||Frontier Acquisition Corp.|
|Revenues||$0 mil (last 12 months)|
|Net Income||$0 mil (last 12 months)|
|Price range||$10.00 - $10.00|
|Est. $ Volume||$200.0 mil|
|Manager / Joint Managers||Credit Suisse|
|Expected To Trade:||3/11/2021|
|Quiet Period Expiration Date:||Available only to Subscribers|
|Lock-Up Period Expiration Date:||Available only to Subscribers|
|SCOOP Rating||Available only to Subscribers|
|Rating Change||Available only to Subscribers|